Topics

Affinivax, Inc. Company Profile

07:31 EDT 18th September 2019 | BioPortfolio

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infectious diseases. Backed by an investment from the Bill & Melinda Gates Foundation, and working with world experts in vaccine discovery and development, Affinivax is focused on creating a pipeline of vaccines for children and adults in both the developed and developing worlds. The company’s proprietary vaccine platform, called Multiple Antigen Presentation System (MAPS), enables the high affinity binding of protective polysaccharides and proteins in a single vaccine and uniquely induces a broad and protective immune response. The MAPS technology provides a highly stable, modular, and efficient approach to develop vaccines against a wide range of diseases. The company has achieved preliminary preclinical proof-of-concept for several MAPS vaccines and is currently advancing its lead vaccine candidate against Streptococcus pneumoniae. Affinivax initiated a collaboration with PATH in early 2015 to help support the advancement of its lead MAPS vaccine candidate for Streptococcus pneumoniae (pneumococcal disease), and since September 2015, Affinivax has collaborated with Astellas and its R&D partner, ClearPath Development Company to research and develop MAPS vaccines to prevent bacterial nosocomial infections. For more information, visit www.affinivax.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Affinivax and Astellas begin Phase I/II trial of pneumococcal vaccine

Affinivax and its development partner Astellas have commenced a Phase I/II clinical trial to investigate ASP3772 vaccine against infection caused by...Read More... The post Affinivax and Astellas beg...

Affinivax’s MAPS Vaccine Technology Reaches Clinic In Under Five Years

Funded entirely by grants and partnerships to date, Affinivax’s pneumococcal vaccine candidate has begun a Phase I/II study less than...  

Affinivax Announces Initiation of Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collab with #Astellas https://www.businesswire.com/news/home/20190213005155/en/Affinivax-Announces-Initiation-Phase-12-Clinical-Study …

Affinivax Announces Initiation of Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collab with #Astellas https://www.businesswire.com/news/home/20190213005155/en/Affiniva...

Frank Malinoski, MD, PhD, joins Affinivax as Senior Vice President of Clinical Development and Regulatory Affairs

Industry veteran brings over 30 years of development and commercial experience across multiple vaccine and immunotherapy products Affinivax, Inc. ("Affinivax"...

Affinivax, Inc. Announces Initiation of Phase 1/2 Clinical Study of ASP3772, Its Novel Pneumococcal MAPS Vaccine, in Collaboration with Astellas

Clinical study will evaluate safety, tolerability, and immunogenicity in adults Initiation of clinical study triggers milestone payment to Affinivax Affinivax,...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Affinivax, Inc.

Affinivax is advancing a next generation vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challenging infecti...

Affinivax Inc.

Affinivax is advancing a next generation conjugate vaccine technology platform to enable the development of vaccines that provide the highest level of protection against challengi...

More Information about "Affinivax, Inc." on BioPortfolio

We have published hundreds of Affinivax, Inc. news stories on BioPortfolio along with dozens of Affinivax, Inc. Clinical Trials and PubMed Articles about Affinivax, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Affinivax, Inc. Companies in our database. You can also find out about relevant Affinivax, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record